CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 99 enrolled
Drug / intervention
Blood withdrawalother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01098006
NCT01098006N/ACompleted

A Study in Adult Subjects With Chronic Hepatitis B Infection to Support the Development of Immunological Assays

GlaxoSmithKline·interventional·Posted Apr 2, 2010·Updated Feb 25, 2020

In Brief

A clinical study evaluating Blood withdrawal for Immunologic Tests. Completed, enrolled 99 participants across 2 sites.

Detailed Summary

The purpose of this study is to develop and characterize immunological assays on blood samples.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesBelgium
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 2, 2010
Enrollment StartApr 29, 2010
Primary CompletionFeb 20, 2012
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 16.3 years ago

Interventions

Blood withdrawalother

A single blood sample was to be taken from all subjects at the study visit. No study-related treatment was given to the study participants.